Assessment of magnesium sulphate usage in pre-eclamptic and eclamptic women in Omdurman Maternity Hospital, 2017: A cross-sectional study

Name	World Continuing Education Alliance
Activity Title	Assessment of magnesium sulphate usage in pre-eclamptic and eclamptic women in Omdurman Maternity Hospital, 2017: A cross-sectional study
Details	Preeclampsia/eclampsia is a pregnancy-specific disease with multisystem physiological disorder, which may lead to increased risk of maternal and perinatal mortality and morbidity. Magnesium sulphate (MgSO. In Sudan, preeclampsia/eclampsia is considered as one of the main factors leading to an increase in morbidity and mortality among pregnant womenn Objectives Course Objective Eclampsia, the end phenomena of the preeclampsia spectrum, appears as new onset grand mal seizures in women with preeclampsia. Recently, the World Health Organization has recommended magnesium sulphate (MgSo4) as the main drug of choice to treat/prevent eclampsia. However, in Sudan no real assessment data about MgSo4 efficacy, benefits and risks in preeclamptic and eclamptic women has been reported.. A cross-sectional hospital-based study was conducted between January and April 2017 at Omdurman Maternity Hospital using a checklist.
Competence	Public Health
Start Date	<span class="not-set">(not set)</span>
End Date	<span class="not-set">(not set)</span>
Event Time	05:15 PM
Location	World Continuing Education Alliance eLearning System
Cost (UGX)	0
CPD Points	1